Two lots of blood pressure medication are being recalled over concerns that it has too much of an impurity, according to the U.S. Food and Drug Administration.
Aurobindo Pharma is recalling lot Nos. QE2021005-A and QE2021010-A of Quinapril and Hydrochlorothiazide Tablets USP 20mg/12.5mg. The 90-count bottles have an expiration day of January 2023.
According to the notice, while nitrosamines are common, “These impurities may increase the risk of cancer if people are exposed to them above acceptable levels over long periods of time.”
According to the FDA recall notice, the tablets are, “Pink colored, scored, round shaped, biconvex, film-coated tablets, debossed with ‘D’ on the scored side and ‘19′ on the other side.”
The recall comes three weeks after a packaging mix-up led to the recall of a blood pressure medication and a second medication designed to lower the risk of having a stroke or serious heart problems, the U.S. Food and Drug Administration reported.
If customers have any questions about returning the recalled drugs, they can call 888-504-2014, Monday through Friday, 8 a.m.-5 p.m. ET.
©2022 Cox Media Group